ASA: Adjuvant Methylprednisolone Role Examined in Acute Ischemic Stroke
No improvement seen in overall disability with methylprednisolone adjuvant to endovascular thrombectomy
Stay updated with breaking news from Qingwu Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
No improvement seen in overall disability with methylprednisolone adjuvant to endovascular thrombectomy
No improvement seen in overall disability with methylprednisolone adjuvant to endovascular thrombectomy
This clinical trial assesses the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for patients wit
Trial disappoints, but another hints at benefit for tirofiban in this stroke population
email article Two small trials added to the evidence that some stroke patients could fare well going straight to mechanical thrombectomy without IV thrombolysis, though the studies were confined to Asian populations and non-inferiority was not shown in the strictest sense. For patients with acute ischemic stroke due to large vessel occlusion, results were inconclusive (but somewhat favorable) for a strategy of skipping the IV tissue plasminogen activator (tPA) usually recommended prior to mechanical thrombectomy in the Japanese SKIP trial. However, a similar strategy did prove to be non...